The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent.

J Gen Intern Med

Department of Urology, University of Pittsburgh Medical Center, 5200 Centre Avenue, Suite 209, Pittsburgh, PA, 15232, USA.

Published: February 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858345PMC
http://dx.doi.org/10.1007/s11606-021-07000-3DOI Listing

Publication Analysis

Top Keywords

costs delayed
4
delayed generic
4
generic drug
4
drug entry
4
entry evidence
4
evidence controversial
4
controversial prostate
4
prostate cancer
4
cancer drug
4
drug patent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!